We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Tissue-Integrated Sensitive Glucose Nanosenor to Revolutionize Diabetes Management

By HospiMedica International staff writers
Posted on 03 Jan 2024

The key task of monitoring blood glucose levels is typically accomplished through the use of enzyme glucose oxidase (GOx)-based electrochemical sensors. More...

Despite their effectiveness, these sensors produce the toxic byproduct hydrogen peroxide and also require cumbersome electrical components and batteries, complicating the development of continuous, implantable monitoring devices. An alternative approach involves single-wall carbon nanotubes (SWCNTs), which, when excited by light, emit near-infrared fluorescence that penetrates tissue and can be captured by non-invasive bioimaging techniques. However, integrating GOx with SWCNTs to create nanosensors is challenging as the typical method for attaching molecules to SWCNTs, sonication, deactivates the GOx molecules.

To address these challenges, scientists at the University of California, Berkeley (Berkeley, CA, USA) have innovated a battery-free fluorescent nanosensor that combines SWCNTs with an inactive form of GOx. This groundbreaking design allows for the continuous, reversible, and non-invasive bioimaging of glucose levels in body fluids and tissues. This development overturns the prevailing belief that GOx-based sensors require active GOx for effective glucose sensing. Through sonication, the team produced GOx-loaded SWCNT sensors capable of accurately and selectively detecting glucose in various mediums like serum, plasma, and even within mouse brain tissue.

According to the researchers, inactive GOx enzyme can still bind to glucose without converting it, and binding alone proved sufficient to modulate the fluorescence signal. In order to be completely independent of GOx activity, the researchers also created a GOx enzyme that even lacked the reactive group for glucose conversion. The resulting apo-GOx-SWCNT sensor was able to detect glucose in body fluids and mouse brain slices as reliably as the original conjugate of SWCNT and natural GOx. The researchers suggest that the use of inactive GOx molecules offers key advantages. For instance, it is possible to simplify the manufacturing process of the GOx-SWCNT nanosensors by utilizing sonication as an effective preparation step. Additionally, since the analyte is not consumed by the enzyme reaction, there are no toxic byproducts produced, and the measurements are intrinsically reversible, enabling the non-invasive continuous monitoring of glucose in tissue fluids.

Related Links:
University of California, Berkeley


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.